{"id":"W4225684867","doi":"10.1097/01.ogx.0000805152.09501.f1","title":"Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer","year":2022,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Pembrolizumab; Bevacizumab; Oncology; Chemotherapy; Cervical cancer; Internal medicine; Paclitaxel; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002788079,0.0002261929,0.0004115402,0.0002406784,0.0001953529,0.0003703824,0.0001822929,0.0004289493,0.01736888],"category_scores_gemma":[0.0004102564,0.00009236766,0.000307182,0.0002668257,0.00008936945,0.0002201317,0.0001274003,0.000725201,0.002221508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004188897,"about_ca_system_score_gemma":0.0004584208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002556101,"about_ca_topic_score_gemma":0.008718655,"domain_scores_codex":[0.9999137,0.00002375614,0.000006777859,0.00001413671,0.00002306935,0.00001847186],"domain_scores_gemma":[0.9999017,0.00002531066,0.00001717928,0.000004402933,0.000014418,0.00003708123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02282294,0.00065613,0.01525868,0.002275285,0.0007877724,0.0006740012,0.00003191525,0.0003964581,0.00692977,0.0007238919,0.4597374,0.489706],"study_design_scores_gemma":[0.02086889,0.01253006,0.3000526,0.002231905,0.002196686,0.002846752,0.0001276338,0.00190806,0.00470966,0.001306227,0.6511665,0.00005504952],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.316706,0.3945944,0.001085342,0.04670003,0.01096533,0.0008645693,0.03264766,0.000641422,0.1957953],"genre_scores_gemma":[0.7847071,0.09638384,0.001034531,0.01451852,0.00474286,0.0002896632,0.01271701,0.00003280305,0.08557367],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01736888,"threshold_uncertainty_score":0.05810469,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1206040151824032,"score_gpt":0.3571078776410807,"score_spread":0.2365038624586774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}